Poolbeg Pharma (POLB) News Today → This is the best new way to score with AI (From Weiss Ratings) (Ad) Free POLB Stock Alerts GBX 13.25 -0.30 (-2.24%) (As of 04:28 PM ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 15 at 5:17 AM | msn.comThis 13p penny stock’s on fire! Should I buy it?May 7, 2024 | marketbeat.comPoolbeg Pharma (LON:POLB) Trading 17.3% Higher Poolbeg Pharma (LON:POLB) Trading 17.3% HigherMay 1, 2024 | lse.co.ukPoolbeg Pharma celebrates full patent approval for Immunomodulator IIMay 1, 2024 | finance.yahoo.comPoolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drugMay 1, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Significant POLB 001 Patent Granted in USAApril 30, 2024 | marketbeat.comPoolbeg Pharma (LON:POLB) Sets New 1-Year High at $12.20Poolbeg Pharma (LON:POLB) Hits New 1-Year High at $12.20April 30, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Results for the Year Ended 31 December 2023April 29, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces TR-1: Notification of Major HoldingsMarch 27, 2024 | finance.yahoo.comFavourable Signals For Poolbeg Pharma: Numerous Insiders Acquired StockMarch 20, 2024 | proactiveinvestors.comPoolbeg Pharma moves closer to locking down IP protection for key...February 22, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Director/PDMR ShareholdingFebruary 20, 2024 | finance.yahoo.comPoolbeg Pharma chair discusses shift to executive role; hVIVO share saleFebruary 19, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Director Share PurchaseFebruary 15, 2024 | finance.yahoo.comWe Think Poolbeg Pharma (LON:POLB) Can Afford To Drive Business GrowthFebruary 15, 2024 | msn.comPoolbeg Pharma announces board role change and launch of EIPFebruary 15, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Board Role Change and Launch of EIPFebruary 12, 2024 | finance.yahoo.comPoolbeg Pharma says research confirms $10B plus opportunity for POLB 001 in cancer immunotherapiesFebruary 12, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Market Opportunity for POLB 001 for CRSFebruary 8, 2024 | finance.yahoo.comPoolbeg Pharma's new VP of Clinical Operations Laura Maher aims to help progress development assetsJanuary 17, 2024 | finance.yahoo.comPoolbeg Pharma PLC Announces Further Data Shows POLB001 Potential in Cancer CRSDecember 20, 2023 | msn.comPoolbeg Pharma identifies promising RSV drug candidates as part of AI-led programmeDecember 20, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces RSV AI Drug Candidate Analysis UpdateDecember 11, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces POLB 001 Data Presented at ASHNovember 30, 2023 | proactiveinvestors.comPoolbeg Pharma non-exec steps down from boardNovember 30, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces Directorate ChangeNovember 21, 2023 | lse.co.ukTRADING UPDATES: Poolbeg hails approval; EDX links with Thermo FisherNovember 21, 2023 | proactiveinvestors.comPoolbeg Pharma lands Japanese patent grant for lead assetNovember 21, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces Immunomodulator II Patent Granted in JapanNovember 9, 2023 | finance.yahoo.comFormer Amryt Pharma Leadership Team join PoolbegNovember 2, 2023 | finance.yahoo.comPoolbeg Pharma "continuing its campaign to find a partner" for POLB001November 1, 2023 | proactiveinvestors.comPoolbeg investor meeting will take a deep dive into lead programmeNovember 1, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces POLB 001 Oncology Programme Update MeetingOctober 26, 2023 | proactiveinvestors.comPoolbeg advisory board endorses flu drug approachOctober 17, 2023 | proactiveinvestors.comPoolbeg Pharma unveils new collaboration agreementOctober 17, 2023 | finance.yahoo.comPoolbeg Partners with a Nasdaq-Listed BiopharmaSeptember 29, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces Favourable Conclusion of Patent OppositionSeptember 20, 2023 | proactiveinvestors.comPoolbeg Pharma shores up protection around its IPSeptember 19, 2023 | proactiveinvestors.comPoolbeg Pharma: Third party withdraws patent oppositionSeptember 19, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces Immunomodulator I Patent Opposition WithdrawalSeptember 13, 2023 | finance.yahoo.comPoolbeg Pharma "moving forward rapidly" with POLB001September 13, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces Interim Results for the Six Months to 30 June 2023September 8, 2023 | finance.yahoo.comWe're Not Very Worried About Poolbeg Pharma's (LON:POLB) Cash Burn RateAugust 30, 2023 | proactiveinvestors.comPoolbeg Pharma highlights climate change impact on infectious diseasesJune 29, 2023 | lse.co.ukPoolbeg Pharma makes "significant" influenza breakthrough with AIJune 29, 2023 | msn.comPoolbeg Pharma identifies multiple novel drug targets for flu treatmentJune 29, 2023 | finance.yahoo.comPoolbeg Pharma and CytoReason identify "very exciting influenza targets"June 29, 2023 | finance.yahoo.comPoolbeg Pharma PLC Announces AI Led Programme Identifies Influenza Drug TargetsJune 22, 2023 | proactiveinvestors.comSmall cap snapshot: Erdene Resources, Valeo Pharma, Avicanna, PyroGenesis, Evergreen Sustainable Enterprises...June 22, 2023 | finance.yahoo.comPoolbeg Pharma sees "significant commercial opportunity" in oral vaccinesJune 22, 2023 | proactiveinvestors.comPoolbeg Pharma consortium moves into important new phase as...Poolbeg Pharma consortium moves into important new phase as it... Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Email Address He cracked the code to crypto… (Ad)Juan Villaverde has cracked the code to crypto. Click now for the best way into the newest AI projects POLB Media Mentions By Week POLB Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. POLB News Sentiment▼0.000.56▲Average Medical News Sentiment POLB News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. POLB Articles This Week▼11▲POLB Articles Average Week Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SCLP News Today REDX News Today ETX News Today FARN News Today AREC News Today C4XD News Today SAR News Today FUM News Today OKYO News Today HEMO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:POLB) was last updated on 5/15/2024 by MarketBeat.com Staff From Our PartnersDoes this make you sick?Allegiance GoldThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Monetary GoldForget the “Magnificent 7” Tech Companies, Buy This AI Stock InsteadBanyan Hill PublishingTop 5 Tech Stocks to Buy for 2024Daily Market AlertsTop 5 AI Stocks to Buy for 2024Market Moving Trendsis this a buy and hold stock?Tips4TradersWith revenue forecasted to grow dramatically in 2024 and beyond, this company should be on your radarStocks News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
